- Home
- LNW vs ASND Comparison
LNW vs ASND Comparison
Compare LNW & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNW
- ASND
- Stock Information
- Founded
- LNW 1984
- ASND 2006
- Country
- LNW United States
- ASND Denmark
- Employees
- LNW N/A
- ASND N/A
- Industry
- LNW EDP Services
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- LNW Technology
- ASND Health Care
- Exchange
- LNW Nasdaq
- ASND Nasdaq
- Market Cap
- LNW N/A
- ASND 9.9B
- IPO Year
- LNW N/A
- ASND 2015
- Fundamental
- Price
- LNW $87.87
- ASND $151.43
- Analyst Decision
- LNW Buy
- ASND Strong Buy
- Analyst Count
- LNW 11
- ASND 14
- Target Price
- LNW $110.91
- ASND $201.79
- AVG Volume (30 Days)
- LNW 709.5K
- ASND 409.7K
- Earning Date
- LNW 05-07-2025
- ASND 05-01-2025
- Dividend Yield
- LNW N/A
- ASND N/A
- EPS Growth
- LNW 110.29
- ASND N/A
- EPS
- LNW 3.68
- ASND N/A
- Revenue
- LNW $3,188,000,000.00
- ASND $376,478,932.00
- Revenue This Year
- LNW $8.88
- ASND $61.43
- Revenue Next Year
- LNW $6.48
- ASND $73.07
- P/E Ratio
- LNW $23.89
- ASND N/A
- Revenue Growth
- LNW 9.86
- ASND 36.34
- 52 Week Low
- LNW $84.00
- ASND $111.09
- 52 Week High
- LNW $115.00
- ASND $169.37
- Technical
- Relative Strength Index (RSI)
- LNW 31.29
- ASND 47.14
- Support Level
- LNW $84.98
- ASND $143.81
- Resistance Level
- LNW $108.27
- ASND $161.91
- Average True Range (ATR)
- LNW 3.38
- ASND 6.32
- MACD
- LNW -2.44
- ASND -1.66
- Stochastic Oscillator
- LNW 12.41
- ASND 29.81
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.